அமெரிக்கன் தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அமெரிக்கன் தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அமெரிக்கன் தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் Today - Breaking & Trending Today

Experts argue against ivermectin use

Daily Maverick 168 weekly newspaper.
As the South African Health Products Regulatory Authority (Sahpra) settled several court applications on Tuesday 6 April to provide wider access to ivermectin for the treatment of Covid-19, the country’s infectious disease specialists insisted that this was not the right way to do it.
Despite battling through two brutal waves of the Covid-19 pandemic, South Africa’s frontline doctors, all infectious disease specialists, were among a group of esteemed medical experts who told the court that it was not in the public interest to allow broad access to ivermectin through legal action, insisting that evidence of the drug’s efficacy and safety were still lacking. ....

Kwazulu Natal , South Africa , Free State , United States , South African , Sahpra Yuven Gounden , Steve Swart , Aslam Dasoo , Halima Dawood , George Coetzee , Andrew Hill , Gauteng High Court , Treatment Action Campaign , Practitioners Group , University Of Liverpool , American National Institutes Of Health , African Christian Democratic Party , African Health Products Regulatory Authority Sahpra , Science Reference Group For Covid , Clinicians Society , National Institutes Of Health , Allergy Society Of South African , Committee On Covid , Critical Care Alliance , World Health Organisation , Journal Of The American Medical Association ,

Doctors say COVID vaccine should be tested on pregnant women

Doctors say COVID vaccine should be tested on pregnant women
Save
Normal text size
Advertisement
A demand by Australian womenâs health experts that pregnant and breastfeeding women be included in clinical trials of COVID-19 vaccines was ignored, and doctors say leaving them out is discriminatory.
Representatives of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists and the Breastfeeding Association of Australia, and midwifery expert associate professor Karleen Gribble said pregnant women should have been allowed to volunteer for vaccine trials and the fact they were not means âmany more women are at riskâ.
Pregnant and breastfeeding women were not included in vaccine trials for COVID-19 but some womenâs health experts argue it was discriminatory not to have included them. ....

United States , New South Wales , United Kingdom , Wendy Tuohy , Vijay Roach , Karleen Gribble , William Petri , Sydney University , American Academy Of Pediatrics , Centers For Disease , Us Coalition To Advance Maternal Therapeutics , Virginia University , Drug Administration , Most Viewed In National , Australian Breastfeeding Association , American National Institutes Of Health , American College Of Obstetricians , Western Sydney University , American College , Adjunct Professor , Professor Gribble , American National Institutes , Australian Breastfeeding , Advance Maternal Therapeutics , American Academy , Associate Professor ,

Moderna gets emergency use authorisation for its COVID-19 vaccine in US

Moderna gets emergency use authorisation for its COVID-19 vaccine in US
Representative Image
Moderna has become the second company to get emergency use authorisation for its anti-coronavirus vaccine from the US Food and Drug Administration (FDA), a week after the one developed by Pfizer received a similar approval.
According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).
Congratulations, the Moderna vaccine is now available! President Donald Trump tweeted soon after.
The FDA based its recommendation on the totality of scientific evidence shared by Moderna, including a data analysis from the pivotal phase three clinical study announced on November 30. The primary efficacy analysis conducted on 196 cases indicated a vaccine efficacy rate of 94.1 per cent. ....

United States , Alex Azar , Michael Burgess , Stephenm Hahn , Donald Trump , Mike Pence , Centers For Disease , Human Services , Department Of Defense , National Institutes Of Health , Drug Administration , House Rules Committee , Advisory Committee On Immunization Practices , American National Institutes Of Health , Commerce Subcommittee On Health , Republican Leader Of The House Energy , Department Of Health , President Mike Pence , Secretary Alex Azar , National Institutes , Biologics License Application , Chief Executive Officer , Disease Control , Advisory Committee , Immunization Practices , Operation Warp Speed ,